GlassScriptPhysician profile
Gregg Kottyan
NPI 1083904155
$1,767.42
in general payments reported to CMS, 2019-2025
15 companies · $178 in 2025
The $178 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $178 · 2021: $238 · 2022: $322 · 2023: $237 · 2024: $371 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $785.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $380.74 | 2021-2025 | |
| Glaxosmithkline, LLC. | $336.26 | 2019-2024 | Bexsero |
| Merck Sharp & Dohme LLC | $215.03 | 2020-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Tris Pharma INC | $181.46 | 2019-2025 | Dyanavel Xr |
| Kaleo, INC. | $179.89 | 2019-2024 | Auvi-Q |
| Cranial Technologies, INC | $147.11 | 2019-2024 | Doc Band |
| Seqirus USA INC | $72.09 | 2021-2024 | Flucelvax |
| Takeda Pharmaceuticals U.S.A., INC. | $65.48 | 2020-2022 | |
| Ironshore Pharmaceuticals INC. | $46.68 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $46.51 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $23.07 | 2024 | Flumist Quadrivalent |
| Corium, LLC | $21.04 | 2021 | |
| Sobi, INC | $18.79 | 2021 | |
| Shire North American Group INC | $18.13 | 2019 | |
| Sanofi Pasteur INC. | $15.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregg Kottyan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.